Pharmacoeconomic analysis of DPP-4 inhibitors

Author： Teramachi H.   Ohta H.   Tachi T.   Toyoshima M.   Mizui T.   Goto C.   Tsuchiya T.  

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.68, Iss.11, 2013-11, pp. : 909-915

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Exploration of the DPP-4 inhibitors with a focus on saxagliptin

By Shubrook Jay H   Colucci Randall A   Schwartz Frank L  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2927-2934

Informa Healthcare

Access to resources Recommend Favorite

Fragment Based HQSAR Modeling and Docking Analysis of Conformationally Rigid 3-azabicyclo [3.1.0] Hexane Derivatives to Design Selective DPP-4 Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 2, 2014-02 ,pp. : 184-198

Bentham Science Publishers

Access to resources Recommend Favorite

Structure Based Lead Optimization Approach in Discovery of Selective DPP4 Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-05 ,pp. : 888-914

Bentham Science Publishers

Access to resources Recommend Favorite

In Silico Study of Flavonoids as DPP-4 and #945;-glucosidase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 15, Iss. 6, 2018-04 ,pp. : 634-642

Bentham Science Publishers

Access to resources Recommend Favorite

Incretin therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors

By Ahrén Bo  

European Diabetes Nursing, Vol. 10, Iss. 1, 2013-03 ,pp. : 31-36

Blackwell Publishing

Access to resources Recommend Favorite